Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase by Agrawal Vishal, Choi Ji Ha, Giacomini Kathleen M, Miller Walter L in Pharmacogenetics and genomics (2010).

[PMID: 20697309] PubMed


CYP3A4 receives electrons from P450 oxidoreductase (POR) to metabolize about 50% of clinically used drugs. There is substantial inter-individual variation in CYP3A4 catalytic activity that is not explained by CYP3A4 genetic variants. CYP3A4 is flexible and distensible, permitting it to accommodate substrates varying in shape and size. To elucidate the mechanisms of variability in CYP3A4 catalysis, we examined the effects of genetic variants of POR, and explored the possibility that substrate-induced conformational changes in CYP3A4 differentially affect the ability of POR variants to support catalysis.

[ hide abstract ]

Discussed In Paper


Dosing Information

No dosing information annotated.